Immunodominance of antigenic site B over site a of hemagglutinin of recent H3N2 influenza viruses

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Popova, Lyubov ^a,b   Smith, Kenneth ^c   West, Ann H ^b   Wilson, Patrick C ^c,d   James, Judith A ^c   Thompson, Linda F ^c   Air, Gillian M ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ARTICLE; BINDING SITE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INFECTION PREVENTION; INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; SEASONS; SPECIES SPECIFICITY; VACCINATION;

ORTHOMYXOVIRIDAE;

EID: 84864350660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041895     Document Type: Article

References (52)

1. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, et al. (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control 59: 1-62.
2. Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, et al. (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109: 4269-4274.
3. Skehel JJ, Wiley DC, (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
4. Gerhard W, Webster RG, (1978) Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med 148: 383-392.
5. Webster RG, Laver WG, (1980) Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104: 139-148.
6. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, et al. (1984) A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81: 1779-1783.
7. Laver WG, Air GM, Webster RG, Smith-Gill SJ, (1990) Epitopes on protein antigens: misconceptions and realities. Cell 61: 553-556.
8. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W, (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427.
9. Wiley DC, Skehel JJ, (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365-394.
10. Laver WG, Air GM, Webster RG, Gerhard W, Ward CW, et al. (1979) Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. Virology 98: 226-237.
11. Webster RG, Laver WG, Air GM, Ward C, Gerhard W, et al. (1980) The mechanism of antigenic drift in influenza viruses: analysis of Hong Kong (H3N2) variants with monoclonal antibodies to the hemagglutinin molecule. Ann N Y Acad Sci 354: 142-161.
12. Wilson IA, Skehel JJ, Wiley DC, (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289: 366-373.
13. Wiley DC, Wilson IA, Skehel JJ, (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
14. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM, (1999) Predicting the evolution of human influenza A. Science 286: 1921-1925.
15. Sato K, Morishita T, Nobusawa E, Tonegawa K, Sakae K, et al. (2004) Amino-acid change on the antigenic region B1 of H3 haemagglutinin may be a trigger for the emergence of drift strain of influenza A virus. Epidemiol Infect 132: 399-406.
16. Seidel W, Kunkel F, Geisler B, Garten W, Herrmann B, et al. (1991) Intraepidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch Virol 120: 289-296.
17. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, et al. (2007) N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 81: 8593-8600.
18. Wanzeck K, Boyd KL, McCullers JA, (2011) Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med 183: 767-773.
19. Knossow M, Gaudier M, Douglas A, Barrere B, Bizebard T, et al. (2002) Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302: 294-298.
20. Knossow M, Skehel JJ, (2006) Variation and infectivity neutralization in influenza. Immunology 119: 1-7.
21. Whittle JRR, Zhang R, Khurana S, King LR, Manischewitz J, et al. (2011) Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 108: 14216-14221.
22. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, et al. (1995) Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376: 92-94.
23. Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, et al. (1999) A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol 6: 530-534.
24. Fleury D, Wharton SA, Skehel JJ, Knossow M, Bizebard T, (1998) Antigen distortion allows influenza virus to escape neutralization. Nat Struct Biol 5: 119-123.
25. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333: 850-856.
26. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251.
27. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
28. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360.
29. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333: 843-850.
30. Steel J, Lowen AC, T TW, Yondola M, Gao Q, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1 e-published May 18.
31. Rossmann MG, (1989) The canyon hypothesis. Viral Immunol 2: 143-161.
32. Laver WG, Air GM, Webster RG, (1981) Mechanism of antigenic drift in influenza virus. Amino acid sequence changes in an antigenically active region of Hong Kong (H3N2) influenza virus hemagglutinin. J Mol Biol 145: 339-361.
33. Smith CA, Barnett BC, Thomas DB, Temoltzin-Palacios F, (1991) Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin. J Exp Med 173: 953-959.
34. Temoltzin-Palacios F, Thomas DB, (1994) Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses. J Exp Med 179: 1719-1724.
35. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, et al. (2004) Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78: 9605-9611.
36. Pan K, Long J, Sun H, Tobin GJ, Nara PL, et al. (2011) Selective pressure to increase charge in immunodominant epitopes of the H3 hemagglutinin influenza protein. J Mol Evol 72: 90-103.
37. Nobusawa E, Omagari K, Nakajima S, Nakajima K, (2012) Reactivity of human convalescent sera with influenza virus hemagglutinin protein mutants at antigenic site A. Microbiol Immunol 56: 99-106.
38. Ohshima N, Iba Y, Kubota-Koketsu R, Asano Y, Okuno Y, et al. (2011) Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J Virol 85: 11048-11057.
39. Bush RM, Fitch WM, Bender CA, Cox NJ, (1999) Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16: 1457-1465.
40. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, et al. (2004) Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303: 1866-1870.
41. Garten W, Bosch FX, Linder D, Rott R, Klenk HD, (1981) Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology 115: 361-374.
42. Gething MJ, McCammon K, Sambrook J, (1986) Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport. Cell 46: 939-950.
43. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, et al. (2008) Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671.
44. Chen Z, Zhou H, Jin H, (2010) The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response. Vaccine 28: 4079-4085.
45. Arnold K, Bordoli L, Kopp J, Schwede T, (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201.
46. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T, (2009) The SWISS-MODEL Repository and associated resources. Nucleic Acids Res 37: D387-392.
47. Okada J, Ohshima N, Kubota-Koketsu R, Iba Y, Ota S, et al. (2011) Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. J Gen Virol 92: 326-335.
48. Liu C, Air GM, (1993) Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 194: 403-407.
49. Kobasa D, Rodgers ME, Wells K, Kawaoka Y, (1997) Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol 71: 6706-6713.
50. Gulati U, Wu W, Gulati S, Kumari K, Waner JL, et al. (2005) Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Virology 339: 12-20.
51. Feng J, Gulati U, Zhang X, Keitel WA, Thompson DM, et al. (2009) Antibody quantity versus quality after influenza vaccination. Vaccine 27: 6358-6362.
52. Squires B, Macken C, Garcia-Sastre A, Godbole S, Noronha J, et al. (2008) BioHealthBase: informatics support in the elucidation of influenza virus host pathogen interactions and virulence. Nucleic Acids Res 36: D497-503.